The RECONNECT Studies Demonstrated a Clinically Meaningful and Statistically Significant Improvement in the Co-Primary Endpoints of Desire and Associated Distress WALTHAM, Mass., Oct. 11, 2019 (GLOBE ...
Please provide your email address to receive an email when new articles are posted on . Amphastar Pharmaceuticals received FDA approval of its abbreviated new drug application for ganirelix acetate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results